Targeting the NLRP3 inflammasome in cardiovascular diseases

S Toldo, E Mezzaroma, LF Buckley, N Potere… - Pharmacology & …, 2022 - Elsevier
The NACHT, leucine-rich repeat (LRR), and pyrin domain (PYD)-containing protein 3
(NLRP3) inflammasome is an intracellular sensing protein complex that plays a major role in …

The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases

S Toldo, A Abbate - Nature Reviews Cardiology, 2024 - nature.com
An intense, stereotyped inflammatory response occurs in response to ischaemic and non-
ischaemic injury to the myocardium. The NACHT, LRR and PYD domains-containing protein …

NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases

Y Wang, X Liu, H Shi, Y Yu, Y Yu, M Li… - Clinical and …, 2020 - Wiley Online Library
Inflammation is an important process involved in several cardiovascular diseases (CVDs),
and nod‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a vital …

Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse

C Marchetti, S Toldo, J Chojnacki… - Journal of …, 2015 - journals.lww.com
Background: Sterile inflammation resulting from myocardial injury activates the NLRP3
inflammasome and amplifies the inflammatory response mediating further damage …

The role of NLRP3 inflammasome in pericarditis: potential for therapeutic approaches

AG Mauro, A Bonaventura, A Vecchié… - Basic to Translational …, 2021 - jacc.org
Human samples of patients with chronic pericarditis and appropriate control subjects were
stained for the inflammasome components. A mouse model of pericarditis was developed …

The NLRP3 inflammasome inhibitor, OLT1177 (dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse

S Toldo, AG Mauro, Z Cutter… - Journal of …, 2019 - journals.lww.com
Background: Activation of the NLRP3 inflammasome is a primary driver of sterile
inflammation in response to myocardial ischemia reperfusion. Pharmacologic inhibitors of …

The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy

Y Liu, D Wang, T Li, F Yang, Z Li, X Bai… - Frontiers in …, 2022 - frontiersin.org
Skeletal muscle atrophy is a common complication in survivors of sepsis, which affects the
respiratory and motor functions of patients, thus severely impacting their quality of life and …

The inflammasome in myocardial injury and cardiac remodeling

S Toldo, E Mezzaroma, AG Mauro… - Antioxidants & redox …, 2015 - liebertpub.com
Significance: An inflammatory response follows an injury of any nature, and while such a
response is an attempt to promote healing, it may, itself, result in further injury. Recent …

Role of hydrogen sulfide in ischemia‐reperfusion injury

D Wu, J Wang, H Li, M Xue, A Ji… - Oxidative medicine and …, 2015 - Wiley Online Library
Ischemia‐reperfusion (I/R) injury is one of the major causes of high morbidity, disability, and
mortality in the world. I/R injury remains a complicated and unresolved situation in clinical …

Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways

R Mastrocola, C Penna, F Tullio… - Oxidative Medicine …, 2016 - Wiley Online Library
Although the nucleotide‐binding oligomerization domain‐(NOD‐) like receptor pyrin domain
containing 3 (NLRP3) inflammasome has been recently detected in the heart, its role in …